Dupont De Nemours Inc
- Industry
- Specialty Chemicals
- Exchange
- US
- Country
- USA
- IPO date
- Jun 3, 2019
- Employees
- 15,000
- Website
- www.dupont.com
Composite valuation range · conservative $22–$28 / fair $30–$38 / optimistic $45–$55. At $139.96, Above the optimistic ceiling · future growth overdrawn.
At publication $47.71 (May 29, 2026)
Data from EODHD, shown in the reporting currency; for reference only, not investment advice.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
History
DuPont de Nemours, Inc. (NYSE: DD) was incorporated in 2015 and is headquartered in Wilmington, Delaware. It was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019, with an IPO date of June 3, 2019. Between 2021 and 2026 the company underwent multiple major portfolio changes, including the divestiture of its M&M business, the sale of Delrin, the spinoff of the Qnity electronics business, and the sale of Aramids. It completed the electronics business spinoff in the fourth quarter of 2025, after which it was organized into two reporting segments: Healthcare & Water Technologies and Diversified Industrials. Acquisitions including Spectrum, Donatelle, and Sinochem aligned with a strategy of concentrating on medical and water-treatment businesses. Lori Koch has served as CEO since June 2024. In 2025 the company reported continuing-operations net sales of $6.849 billion and Operating EBITDA of $1.628 billion (margin 23.8%).
Industry position
DuPont de Nemours operates as a technology-based materials and solutions company across two segments. Healthcare & Water Technologies covers medical packaging, medical-device components and protective garments, plus filtration and separation technologies for industrial wastewater/energy, municipal drinking water and desalination, and life-sciences markets; Diversified Industrials covers building technologies and industrial technologies. In 2025, Healthcare & Water Technologies generated $3.233 billion in sales (segment EBITDA margin 30.1%) and Diversified Industrials $3.616 billion (segment EBITDA margin 22.1%); in Q1 2026 the two segments recorded $806 million and $875 million respectively. The company markets recognized brands including Tyvek, Tychem, FilmTec, AmberLite, Corian, Vespel, Molykote, Betaforce, and Cyrel. It operated about 82 manufacturing sites in 2025, with international business at roughly 53% of 2025 continuing-operations net sales and China/Hong Kong revenue of about $708 million. Sources of customer stickiness include switching costs tied to validation, certification and process qualification in medical packaging, medical-device components, water-treatment membranes/ion-exchange resins, and critical industrial parts. Comparable peers cited include Aptar, Veralto, Carlisle, and Eastman.